In conclusion, this study revealed that inhibiting oxidative stress and NF-κB-mediated inflammation has a marked impact on the progression of T2D, and in doing so, also maintains metabolic homeostasis, thereby improving NAFLD and hepatic insulin resistance in obesity. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.